INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 152 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $675,488 | -31.9% | 61,075 | -17.2% | 0.00% | -50.0% |
Q1 2023 | $991,213 | +29.9% | 73,806 | +19.7% | 0.00% | 0.0% |
Q4 2022 | $762,833 | +0.4% | 61,668 | +12.9% | 0.00% | 0.0% |
Q3 2022 | $760,000 | +12.8% | 54,603 | +11.7% | 0.00% | +100.0% |
Q2 2022 | $674,000 | -22.3% | 48,886 | -8.4% | 0.00% | -50.0% |
Q1 2022 | $867,000 | -22.6% | 53,385 | -22.5% | 0.00% | 0.0% |
Q4 2021 | $1,120,000 | -2.0% | 68,845 | -10.6% | 0.00% | 0.0% |
Q3 2021 | $1,143,000 | -28.0% | 77,037 | -3.1% | 0.00% | -33.3% |
Q2 2021 | $1,587,000 | +37.2% | 79,483 | +58.3% | 0.00% | +50.0% |
Q1 2021 | $1,157,000 | -61.4% | 50,206 | -58.7% | 0.00% | -66.7% |
Q4 2020 | $2,998,000 | -60.8% | 121,441 | -34.1% | 0.01% | -62.5% |
Q3 2020 | $7,639,000 | +280.8% | 184,213 | +339.6% | 0.02% | +300.0% |
Q2 2020 | $2,006,000 | +60.6% | 41,903 | +111.0% | 0.00% | +33.3% |
Q1 2020 | $1,249,000 | -50.9% | 19,860 | -3.4% | 0.00% | -40.0% |
Q4 2019 | $2,546,000 | +111.5% | 20,561 | +13.3% | 0.01% | +150.0% |
Q3 2019 | $1,204,000 | +60100.0% | 18,154 | +60413.3% | 0.00% | – |
Q4 2017 | $2,000 | 0.0% | 30 | 0.0% | 0.00% | – |
Q3 2017 | $2,000 | -99.9% | 30 | -99.8% | 0.00% | -100.0% |
Q2 2017 | $1,706,000 | +2.7% | 14,092 | -4.0% | 0.00% | 0.0% |
Q1 2017 | $1,661,000 | +16.2% | 14,683 | +12.2% | 0.00% | 0.0% |
Q4 2016 | $1,429,000 | – | 13,083 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 640,688 | $9,514,000 | 1.49% |
CM Management, LLC | 45,000 | $668,000 | 0.50% |
EULAV Asset Management | 660,000 | $9,801,000 | 0.26% |
DLD Asset Management, LP | 225,200 | $3,346,000 | 0.24% |
Virtus ETF Advisers LLC | 21,387 | $318,000 | 0.14% |
GSA CAPITAL PARTNERS LLP | 79,145 | $1,175,000 | 0.12% |
Hennion & Walsh Asset Management, Inc. | 136,720 | $2,030,000 | 0.11% |
ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $2,507,000 | 0.08% |
Inspire Investing, LLC | 31,868 | $473,000 | 0.06% |
DUALITY ADVISERS, LP | 51,196 | $760,000 | 0.06% |